Literature DB >> 9697085

Multiple sclerosis care: an integrated disease-management model.

J Burks1.   

Abstract

A disease-management model must be integrated, comprehensive, individual patient focused and outcome driven. In addition to high quality care, the successful model must reduce variations in care and costs. MS specialists need to be intimately involved in the long-term care of MS patients, while not neglecting primary care issues. A nurse care manager is the "glue" between the managed care company, health care providers and the patient/family. Disease management focuses on education and prevention, and can be cost effective as well as patient specific. To implement a successful program, managed care companies and health care providers must work together.

Entities:  

Mesh:

Year:  1998        PMID: 9697085     DOI: 10.1080/10790268.1998.11719517

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  4 in total

1.  Value, challenges, and satisfaction of certification for multiple sclerosis specialists.

Authors:  Elsie E Gulick; June Halper
Journal:  Int J MS Care       Date:  2014

2.  Improving Healthcare Professional Psychological Well-being in Neurorehabilitation: An Exploratory Study Focusing on Work Stress.

Authors:  Maria Grazia Maggio; Alfredo Manuli; Adriana Andaloro; Antonio Chirieleison; Gianluca La Rosa; Francesca Sciarrone; Antonia Trinchera; Rocco Salvatore Calabrò
Journal:  Innov Clin Neurosci       Date:  2021 Jul-Sep

3.  Cost of managing an episode of relapse in multiple sclerosis in the United States.

Authors:  Judith A O'Brien; Alexandra J Ward; Amanda R Patrick; Jaime Caro
Journal:  BMC Health Serv Res       Date:  2003-09-02       Impact factor: 2.655

4.  Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients.

Authors:  Floriane Calocer; Olivier Dejardin; Karine Droulon; Guy Launoy; Gilles Defer
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.